Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jiangsu Recbio Technology Co., Ltd. plans to issue up to 143 million domestic shares, aiming to bolster its competitiveness and fund research and development initiatives. The shares will be offered to Yangtze River Pharmaceutical at RMB5.59 each, pending approval at an extraordinary general meeting. Investors are advised to remain cautious as the issuance is subject to certain conditions.
For further insights into HK:2179 stock, check out TipRanks’ Stock Analysis page.